TP53 and breast cancer: It was reported that the p53-derived C-terminal peptide (p53C) induced rapid apoptosis in breast cancer cells carrying endogenous p53 mutations or overexpressed wild-type (wt) p53, but was not toxic to nonmalignant human cell lines containing wt p53 [28].